Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 551 - 600 out of 7,335

Document Document Title
WO/2008/010474A1
A charge-transporting varnish comprising a phenylamino-N,N'-diphenylquinonediimine derivative represented by the formula (1) as a charge-transporting substance. It becomes possible to provide a charge-transporting varnish comprising an o...  
WO/2007/147880A1
The present invention relates to substituted 1,3-diphenylpropane derivatives, to the pharmaceutical compositions containing them and to the therapeutic uses thereof, in particular in the fields of human and animal health.  
WO/2007/147879A1
The present invention relates to substituted 1,3-diphenylpropane derivatives, to the pharmaceutical compositions containing them and to the therapeutic uses thereof, in particular in the fields of human and animal health.  
WO/2007/148435A1
A process for producing an ester or an alcohol using a fluoroimidinium sulfonate derivative represented by the general formula (9) or a fluoroimidinium carboxylate derivative represented by the general formula (6) and using an alcohol wi...  
WO/2007/127639A2
This invention relates to novel homotopic prodrugs and medicaments and methods for their preparation, testing and use. In one embodiment, the homotopic prodrug has the general formula (I) wherein (II) is a biologically-active moiety comp...  
WO/2007/124920A1
The present invention relates to a process for making substantially pure racemic sertraline or its pharmaceutically acceptable salts having a cis/trans ratio of greater than about 85: 15% and which is substantially free of its deschloro ...  
WO/2007/118896A1
The present invention relates to new O-carboxymethyl oxime ether compounds which are useful for combating arthropod pests, in particular insects or arachnids. This object is achieved by compounds of formula (I) as defined below and by th...  
WO/2007/119434A1
A pyridazinone compound represented by the formula (I) have excellent effect on weed control and are useful as an active ingredient of herbicides.  
WO/2007/118681A1
The invention relates to a method for producing 8-aryl-octanoyl derivatives, especially chiral 8-aryl-octanoyl amides, as well as novel intermediate products that are used in said method for producing the inventive octanoyl derivatives, ...  
WO/2007/120502A1
A compound of formula (I): wherein R is -CH2OH, -C(O)H, -C(OR3)2H, -C(OR4)(OH)H, -CH=NC6H4C(O)OR5 or -CH=NR6; R1 and R2 are each independently H or CH3; R3 and R4 are each independently H or a straight or branched aliphatic group having ...  
WO/2007/117462A1
A compound of formula (I): wherein R is -CH2OH, -C(O)H5 -C(OR3)2H, -C(OR4)(OH)H, -CH=NC6H4C(O)OR5 or -CH=NR6; R1 and R2 are each independently H or CH3; R3 and R4 are each independently H or a straight or branched aliphatic group having ...  
WO/2007/116112A1
The present invention relates to a method for preparing oxymes that comprises catalytic hydrogenation of the corresponding a, ß-unsaturated nitrocompound using a gold catalyst.  
WO/2007/110548A1
The invention relates to a process of diastereoselective synthesis. This process carries out the diastereoselective alkylation of optically active nopinone to form the compound of formula (I) according to scheme A below, in which: R repr...  
WO/2007/105814A1
Disclosed is a novel pest control agent, particularly an insecticide or an acaricide. Specifically disclosed is a substituted isoxazoline compound represented by the general formula (1) below or a salt thereof. Also disclosed is a pest c...  
WO/2007/099385A1
The present invention relates to dipeptidyl peptidase IV (DPP-IV) inhibitors of formula (1), pharmaceutical compositions containing them, processes for their preparation, and methods for treating disorders mediated by DPP-IV inhibition, ...  
WO/2007/098474A1
Compounds I and II that have agonist activity at one or more of the S1P receptors are provided. The compounds are sphingosine analogs that, after phosphorylation, can behave as agonists at S1P receptors.  
WO/2007/097368A1
Disclosed is a diimmonium salt having a structure represented by the following formula (1). (1) In the formula (1), X represents anions necessary for neutralizing the electric charge, and at least one of R1-R8 represents a group selected...  
WO/2007/091396A1
Disclosed is a compound having S1P receptor antagonist activity, which is useful as an immunosuppressive agent. The compound has few side effects, and is orally administrable. Specifically disclosed are a compound represented by the gene...  
WO/2007/090434A1
The invention relates to compounds of the formula (I) in which A1, A2, R1, R2, R3, R4, R5 and X have the definition specified in the description, to processes and intermediates for preparing them and to their use for controlling pests.  
WO/2007/091406A1
A compound represented by the following general formula (I). (I) (In the formula, R1 represents hydrogen, C1-8 alkyl, C6-20 aryl, or C7-20 arylalkyl; R2 represents hydrogen, C1-18 alkyl, halogeno, nitro, cyano, or amino; n is a number of...  
WO/2007/089022A1
Disclosed is a method for producing an optically active alcohol compound, which is characterized in that a cyclic ether compound and a phenol compound are reacted in the presence of an asymmetric complex which is obtained by reacting an ...  
WO/2007/088878A1
Disclosed is a commercial method which is practically suitable for producing a 2-iminocarboxylic acid derivative and a benzazepinone by a short process under mild conditions. Specifically disclosed is a method for producing a benzazepino...  
WO/2007/089025A1
Disclosed is a method for producing an optically active alcohol compound, which is characterized in that a cyclic ether compound and a phenol compound are reacted in the presence of an asymmetric complex which is obtained by reacting an ...  
WO/2007/086584A1
Disclosed is a compound which can inhibit both of FabI and FabK which are fatty acid synthases to show a wide antibacterial spectrum including Streptococcus pneumoniae, Pseudomonas aeruginosa and Enterococcus faecalis, and therefore can ...  
WO/2007/084162A2
Provided herein are compositions and methods for treating or preventing cancer and autoimmune diseases. Compositions comprise a sirtuin inhibitory compound that decreases the activity of a sirtuin, such as SIRTl or Sir2. Exemplary method...  
WO/2007/079930A1
The present invention relates to substituted cyclohexylmethyl derivatives, to processes for preparing them, to pharmaceuticals comprising these compounds, and to the use of substituted cyclohexylmethyl derivatives for producing pharmaceu...  
WO/2007/080947A1
Disclosed is a compound represented by the following general formula (1). (1) In the formula, A and B independently represent a substituted or unsubstituted heterocyclic group or a substituted or unsubstituted condensed polycyclic hydroc...  
WO/2007/077469A1
The present invention relates to dihydro-2,3-benzodiazepine compounds of high enantiomeric purity according to the general formula (I), which contain an asymmetric centre at the position 4 of the dihydro-2,3-benzodiazepine compound, and ...  
WO/2007/073000A1
A method for producing a compound of formula (I), which comprises reducing a compound of formula (II) with a hydrazine compound: wherein R103, R113, R123, R133, R143, R203, R213, R223, R233 and R243 represent a substituent; the other Rs ...  
WO/2007/071497A1
Compounds of the Formula (I) and (II) wherein M1, M2 and M3 independently of one another are no bond, a direct bond, CO, O, S, SO, SO2 or NR14; provided that at least one of M1, M2 or M3 is a direct bond, CO, O, S, SO, SO2 or NR14; M4 is...  
WO/2007/069773A1
The present invention provides a novel modulator of the TRPV1-receptor function, comprising a compound of the formula; wherein ring A is an optionally substituted carbocycle or heterocycle, ring B is an optionally substituted benzene rin...  
WO/2007/065567A1
Process for preparing compounds of the formula (IX) by a) reacting haloalkyl(thio)acetic acids of the formula (II) with formamides of the formula (III) to vinimidinium salts of the formula (I), b) reacting vinimidinium salts of the formu...  
WO/2007/062183A1
Infrared (IR) radiation absorbing compounds of metal or metalloids with ligands are beneficial for many applications. Schiff base biquinone (SBB) ligands surrounding a metal or metalloid center may be used for laser welding applications,...  
WO/2007/058504A1
The present invention relates to novel compounds accelerating the activity of Peroxisome proliferator-activated receptor gamma (PPARγ) and alpha (PPARα), processes of preparing the same, and pharmaceutical compositions containing the s...  
WO/2006/122020A3
The present invention relates to processes for the production of 4-biphenylylazetidin-2-one derivatives of formula (I).  
WO/2006/081807A3
The invention relates to a novel method for the production of losartan, an imidazol derivative with the chemical name 2-n-butyl-4-chloro-5-hydroxymethyl-1-{[2'-(1H-tetrazol-5-yl) biphenyl-4-]methyl}imidazol and the pharmacologically acti...  
WO/2007/053755A1
Disclosed is a process for preparing substituted anisidines of formula I starting from substituted cyclic hydroxy-ketones II via aromatization through a substituted oxime intermediate IV in which R is C1-C6 alkyl or halogen, and Alk is C...  
WO/2007/052879A1
The present invention relates to irainecalixarene derivatives, iminecalixarene derivative monolayers prepared as a monolayer on a solid substrate by using said iminecalixarene derivatives, a protein chip substrate prepared by fixing all ...  
WO/2006/127205A3
The present invention relates to methods for preparing substituted 3-cyanoquinolines and intermediates obtained by the methods of the present invention. The methods of the invention comprise reacting an N-aryl-2-propanimide with phosphor...  
WO/2007/020381A3
A process for the preparation of a compound of formula (I) wherein: R is an alkynyl group; R1 is alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkyl-alkyl, phenyl and phenylalkyl, it being possible in turn for all of the receding groups to c...  
WO/2007/043736A1
The present invention relates to novel iminecalixarene derivatives, method of preparation thereof, and self-assembled monolayer prepared by the method, fixing method of oligo-DNA by using the self-assembled monolayer, and oligo-DNA chip ...  
WO/2007/039183A1
The invention related to a novel process, novel process steps and novel intermediates useful in the synthesis of pharmaceutically active compounds, especially renin inhibitors, such as Aliskiren. Inter alia, the invention relates to a pr...  
WO/2007/008942A3
Hydrazide compounds with GPCR desensitization inhibitory activity are provided that may be used to influence, inhibit or reduce the action of a G-protein receptor kinase. Pharmaceutical compositions including therapeutically effective am...  
WO/2007/039555A1
Oximether compounds of formula (I) wherein A is selected from A1 and A2; E is O or S(=O)r; r is 0, 1 or 2; X is C-Y or N; Y is halogen, CN, NO2, NH2, OH, SH, R1, OR1, SR1, S(=O)R1, S(=O)2R1, NHR1, NR1R2, C(=O)H, C(=O)R1, C(=O)OH, C(=O)OR...  
WO/2007/036572A1
The invention relates to compounds of formula (I) which contain aldimine, and to the use thereof. Said compounds which contain aldimines are characterised in that they are odour-less and during hydrolysis the odour-free aldehydes are sep...  
WO/2007/036571A1
The invention relates to aldimines of formula (I), the resulting products thereof, in addition to the uses thereof. The compounds containing aldimines and aldimines are characterised in that they are odour-free and during hydrolysis sepa...  
WO/2006/108864A3
This invention is related to new nitrogenated trans-stilbene analog compounds, more specifically, imine, pyrrol and Índole derivatives, with procedures for the preparation and use thereof as pharmaceutical compositions for the treatment...  
WO2006048547A8
The invention relates to synthesis organic chemistry, in particular to a novel method for synthesising zwitterionic benzoquinonemonoimine derivatives, to certain novel obtained derivatives, the use thereof in the form of colorants or dye...  
WO/2006/127893A3
The present invention relates to processes for the production of 4-(biphenylyl)azetidin-2-one phosphonic acid derivatives of formula.  
WO/2007/025434A1
The present invention provides a new chloro-hypnone oxime derivative. The compound is prepared by the reaction of 1-(2,4-dichlorophenyl)-2-imidazol-1-yl-acetaldoxime, chloropropylene and the alkali in solvent. The compound can be used as...  

Matches 551 - 600 out of 7,335